STOCK TITAN

Intra-Cellular Therapies to Present at the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) to Present at Evercore ISI HealthCONx Conference on November 28, 2023. The biopharmaceutical company will discuss its focus on developing therapeutics for CNS disorders. The live webcast can be accessed on the Company's website.
Positive
  • None.
Negative
  • None.

NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023 at 3:25 p.m. ET in Miami, FL.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
212-213-0006


FAQ

What is the event Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) will present at?

The company will present at the 6th Annual Evercore ISI HealthCONx Conference on November 28, 2023.

What does Intra-Cellular Therapies, Inc. focus on?

The company is focused on developing and commercializing therapeutics for central nervous system (CNS) disorders.

Where can the webcast be accessed?

The live and archived webcast can be accessed under 'Events & Presentations' in the Investor Relations section of the Company's website at www.intracellulartherapies.com.

Intra-Cellular Therapies Inc.

NASDAQ:ITCI

ITCI Rankings

ITCI Latest News

ITCI Stock Data

8.87B
101.92M
2.33%
96.38%
1.72%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BEDMINSTER